ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 901

Smokers and Overweight Persons Are At Increased Risk Of New Onset Of Severe Foot Pain and Persistent Severe Foot Pain In a Population Study

Alyssa B. Dufour1, Hylton B. Menz2, Arunima Awale3, Thomas J. Hagedorn3, Virginia A. Casey3, Patricia P. Katz4 and Marian T. Hannan5, 1Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA, 2Lower Extremity and Gait Studies Program, La Trobe University, Bundoora, Victoria 3086, Australia, 3Institute for Aging Research, Hebrew SeniorLife, Boston, MA, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Institute for Aging Research, Hebrew SeniorLife, Dept. of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: foot, longitudinal studies, pain and risk

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Public Health

Session Type: Abstract Submissions (ARHP)

Background/Purpose:  Few studies have evaluated risk factors for patterns of foot pain in the general population, let alone over time.  An understanding of the possible predictors is the first step towards evidence-based interventions.  The purpose of this study was to examine risk factors for the onset and persistent of severe foot pain in men and women of the population-based Framingham Foot Study (FFS).

Methods: The longitudinal FFS included 648 participants who attended baseline (BL, 2002-5) and follow-up (FU, 2005-8) exams. The presence of foot pain at both BL and FU was queried using the question “On most days, do you have pain, aching, or stiffness in either of your feet?” If participants had foot pain, severity was then queried as mild, moderate or severe.  We dichotomized pain severity into 2 pain groups: moderate/severe versus none/mild for each foot.  Two separate analyses were done to examine 1) onset of moderate/severe pain versus none/mild pain and 2) persistent severe/moderate pain versus resolving severe/moderate pain. Two per-foot analyses using logistic regression and generalized estimating equations were used to examine the association between onset versus no foot pain and persistent versus resolving foot pain with potential risk factors (age, sex, body mass index (BMI), current smoking, knee pain, hip pain, and low back pain). Models were also examined by sex.

Results: At BL, average age was 65 years (range 36-86, SD=9), BMI was 29 kg/m2 (SD=5), 51% were female and mean follow-up time was 3 years (range 1-6).  85% had no pain, 5% had onset, 7% had resolving, and 3% had persistent pain.  Female sex and current smoking was associated with a 2-3 fold increased odds of onset of pain.  Increased BMI was associated with a 16-20 fold increased odds of persistent versus resolving pain (Table).

In the sex-specific models, current smoking maintained its effect with onset pain, but was non-significant (ORmen=3.4, p=.07; ORwomen=2.4, p=.11). The elevated odds of persistent pain remained for overweight (OR=14, p=.20) and obese men (OR=7, p=.10) but not for women. These non-significant results are not surprising given the small numbers in individual cells.

Conclusion: A larger study with longer follow-up is needed to identify risk factors and patterns of foot pain over time. Looking at foot disorders, in addition to pain, is also of interest. Nevertheless, in our study current smoking regularly appears to be linked with onset of moderate to severe foot pain, which is in agreement with common clinical observations that smokers develop more foot problems than non-smokers.  Additionally, increased BMI was suggestively linked to persistent moderate to severe foot pain compared to those whose pain resolved.

Table. Odds ratios (OR) and 95% confidence intervals (CI) for the per-foot analysis between onset and persistent moderate/severe foot pain and risk factors in 648 participants (1296 feet)

Onset (N1=67 feet) vs.
No Pain(N0=1104 feet)

Persistent (N1=40 feet) vs.
Resolving (N0=85 feet)

n/ N1

OR (95% CI)

p-value

n/ N1

OR (95% CI)

p-value

Age (10 yr incr)

 

1.23 (0.92,1.64)

0.16

 

1.06 (0.60,1.87)

0.84

Female sex

42/67

1.98 (1.03,3.82)

0.04

28/40

1.14 (0.41,3.18)

0.80

BMI 25-30 vs <25

27/67

1.26 (0.54,2.93)

0.59

16/40

20.67 (2.39,178.74)

0.01

BMI 30+ vs <25

25/67

1.24 (0.57,2.71)

0.59

23/40

16.31 (1.91,139.41)

0.01

Current smoking

14/67

2.76 (1.21,6.28)

0.02

6/40

2.92 (0.69,12.31)

0.15

Knee pain

23/67

1.26 (0.70,2.27)

0.45

15/40

1.11 (0.54,2.31)

0.78

Hip pain

9/67

0.67 (0.29,1.58)

0.36

7/40

0.52 (0.22,1.22)

0.13

Low back pain

29/67

1.69 (0.87,3.26)

0.12

29/40

1.66 (0.57,4.82)

0.35

 


Disclosure:

A. B. Dufour,
None;

H. B. Menz,
None;

A. Awale,
None;

T. J. Hagedorn,
None;

V. A. Casey,
None;

P. P. Katz,
None;

M. T. Hannan,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/smokers-and-overweight-persons-are-at-increased-risk-of-new-onset-of-severe-foot-pain-and-persistent-severe-foot-pain-in-a-population-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology